Michael Melnick, Ph.D.

Vice President, Business Opportunities

Dr. Melnick is Vice President, Business Opportunities for Himalaya Therapeutics, and Vice President of Corporate Development, Asia for BioAtla.  He started his career in biotechnology as a Staff Scientist at New England Biolabs, then cofounded the spinoff company Cell Signaling Technology where he was Vice President of Business and Corporate Development. Dr. Melnick followed his tenure at Cell Signaling Technology as a Venture Partner at CMEA Capital, an investment firm, where he invested in life science, industrial biotech, and cleantech companies. Dr. Melnick received a B.S. and M.S. in Biological Sciences from Stanford University, and a Ph.D. in Genetics from Harvard University.